On the other hand, testosterone treatment of DM II patients resulted in favorable outcomes such as improved glycemic control [27] and decreased need for insulin in insulin-dependent patients.[28] There is also a dose-effect relationship between the dose of testosterone used and degree of insulin resistance [29]. The gene discussed is INS; the disease is Insulin resistance.